Back
Sinopharm Group 10K Form
Sell
31
SHTDF
Sinopharm Group
Last Price:
2.55
Seasonality Move:
-0.8%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SHTDF News And Ratings
See the #1 stock for the next 7 days that we like better than SHTDF
SHTDF Financial Statistics
Sales & Book Value
| Annual Sales: | $84.34B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.33 |
| Price / Book: | 0.77 |
Profitability
| EPS (TTM): | 0.38500 |
|---|---|
| Net Income (TTM): | $1.2B |
| Gross Margin: | $6.86B |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Sinopharm Group Earnings Forecast
Key Sinopharm Group Financial Ratios
- The Gross Profit Margin over the past 18 years for SHTDF is 8.13%.
- The Selling, General & Administrative Expenses for SHTDF have been equal to 4.38% of Gross Profit Margin.
- The Interest Expense is 32.66% of Operating Income.
- The Net Earning history of SHTDF is 1.52% of Total Revenues.
- Per Share Earnings over the last 18 years have been positive in 16 years.
Sinopharm Group Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | SHTDF |
| Website: | sinopharmgroup.com.cn |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 6.22 |
|---|---|
| Forward P/E Ratio: | 0 |
SHTDF Technical Analysis vs Fundamental Analysis
Sell
31
Sinopharm Group (SHTDF)
is a Sell
Is Sinopharm Group a Buy or a Sell?
-
Sinopharm Group stock is rated a Sell
The current Sinopharm Group [SHTDF] share price is $2.55. The Score for SHTDF is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.